• Trial Seeks Participants to Study AVB-500 Plus Imfinzi in Platinum-resistant Ovarian Cancers
  • Switching Chemo Types in Initial Combo May Help Myeloma Patients with Poor Response, Study Says
  • LHON Natural History Study Highlights Improvements in Visual Acuity From Lumevoq Treatment
  • Gaucher Treatment Can Partly Correct Altered Cell Levels in Bone Marrow, Study Says
  • FDA Grants Breakthrough Therapy Status to Tucatinib for Advanced HER2-Positive Breast Cancer
  • Lynparza Particularly Effective in Prostate Cancer Patients Carrying BRCA Mutations, Phase 2 Study Shows
  • Care of Children with Bronchiectasis Lags Those with Cystic Fibrosis, Australian Study Finds
  • NIH Grant Backs Project to Develop New Pain Therapy for SCD Patients
  • FDA Expands Xtandi Approval to Include Metastatic Castration-sensitive Prostate Cancers
  • Adding BL-8040 to Keytruda and Chemo Shows Good Disease Control in Pancreatic Cancer, Phase 2 Trial Shows
  • Meeting with FDA Supports Tazemetostat for Some Follicular Lymphoma
  • ATYR1923 Is Safe, Well-tolerated by Pulmonary Sarcoidosis Patients, Phase 1/2 Trial Shows